PMC:7228307 / 49216-49324 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"987","span":{"begin":41,"end":45},"obj":"Gene"}],"attributes":[{"id":"A987","pred":"tao:has_database_id","subj":"987","obj":"Gene:2213"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"There are circumstances where binding to FcγR is unnecessary or undesirable in the MOA of a therapeutic mAb."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T100","span":{"begin":83,"end":86},"obj":"Disease"}],"attributes":[{"id":"A100","pred":"mondo_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/MONDO_0016702"}],"text":"There are circumstances where binding to FcγR is unnecessary or undesirable in the MOA of a therapeutic mAb."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T842","span":{"begin":41,"end":43},"obj":"http://purl.obolibrary.org/obo/CLO_0052676"},{"id":"T843","span":{"begin":90,"end":91},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"There are circumstances where binding to FcγR is unnecessary or undesirable in the MOA of a therapeutic mAb."}

    LitCovid-sample-Pubtator

    {"project":"LitCovid-sample-Pubtator","denotations":[{"id":"987","span":{"begin":41,"end":45},"obj":"Gene"}],"attributes":[{"id":"A987","pred":"pubann:denotes","subj":"987","obj":"Gene:2213"}],"text":"There are circumstances where binding to FcγR is unnecessary or undesirable in the MOA of a therapeutic mAb."}

    LitCovid-sample-sentences

    {"project":"LitCovid-sample-sentences","denotations":[{"id":"T283","span":{"begin":0,"end":108},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"There are circumstances where binding to FcγR is unnecessary or undesirable in the MOA of a therapeutic mAb."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T283","span":{"begin":0,"end":108},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"There are circumstances where binding to FcγR is unnecessary or undesirable in the MOA of a therapeutic mAb."}